Page last updated: 2024-09-03

sk&f 104856 and epristeride

sk&f 104856 has been researched along with epristeride in 1 studies

Compound Research Comparison

Studies
(sk&f 104856)
Trials
(sk&f 104856)
Recent Studies (post-2010)
(sk&f 104856)
Studies
(epristeride)
Trials
(epristeride)
Recent Studies (post-2010) (epristeride)
14004744

Protein Interaction Comparison

ProteinTaxonomysk&f 104856 (IC50)epristeride (IC50)
3-oxo-5-alpha-steroid 4-dehydrogenase 1Homo sapiens (human)3.4
3-oxo-5-alpha-steroid 4-dehydrogenase 1 Rattus norvegicus (Norway rat)0.0475
3-oxo-5-alpha-steroid 4-dehydrogenase 2Homo sapiens (human)0.0053
3-oxo-5-alpha-steroid 4-dehydrogenase 2Rattus norvegicus (Norway rat)0.05

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballard, S; Blagg, J; Fox, D; Kenny, B1

Reviews

1 review(s) available for sk&f 104856 and epristeride

ArticleYear
Pharmacological options in the treatment of benign prostatic hyperplasia.
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship

1997